DC44SMe is a phosphate prodrug of a DNA alkylating agent used for the synthesis of antibody-drug conjugates (ADCs); it exhibits potent cytotoxicity against Ramos, Namalwa, and HL60/s cancer cells with IC50 values of 2.0 nM, 2.8 nM, and 1.9 nM, respectively; it is applicable in targeted cancer research.